ENVB
Enveric Biosciences Inc
NASDAQ: ENVB · HEALTHCARE · BIOTECHNOLOGY
$3.95
-23.45% today
Updated 2026-04-30
Market cap
$10.01M
P/E ratio
—
P/S ratio
0.08x
EPS (TTM)
$-36.24
Dividend yield
—
52W range
$2 – $18
Volume
5.0M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.3
Quality
C+3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-56.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$10.00
+153.16%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -56.44 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.78M
- Revenue declining -7.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $35.41M |
| Net income | $-18.50M | $-17291.00 | $-9.57M | $-12.13M | $-2.19M |
| EPS | — | — | — | — | $-36.24 |
| Free cash flow | $-17.73M | $-14.10M | $-7.73M | $-8.14M | $-1.78M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Enveric Biosciences Inc trades at $3.95. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -56.44, it sits in the distress. TTM revenue stands at $35.41M.
Frequently asked questions
What is Enveric Biosciences Inc's stock price?
Enveric Biosciences Inc (ENVB) trades at $3.95.
Is Enveric Biosciences Inc overvalued?
Smart Value Score 29/100 (Grade F, Strong Sell).
What is the price target of Enveric Biosciences Inc (ENVB)?
The analyst target price is $10.00, representing +153.2% upside from the current price of $3.95.
What is Enveric Biosciences Inc's revenue?
TTM revenue is $35.41M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-56.44 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.08x
ROE-304.00%
Beta0.33
50D MA$2.24
200D MA$6.87
Shares out0.00B
Float0.00B
Short ratio—
Avg volume5.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—